Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNFRSF8 anticorps (FITC)

Il existe 1 publication pour ce produit. L’anticorps anti-TNFRSF8 Monoclonal Souris est utilisé pour la détection de TNFRSF8 dans des échantillons de Humain. Il a été validé pour FACS.
N° du produit ABIN192353
356,73 €
Plus frais de livraison 40,00 € et TVA
100 tests
Destination: France
Envoi sous 2 à 4 jours ouvrables

Aperçu rapide pour TNFRSF8 anticorps (FITC) (ABIN192353)

Antigène

Voir toutes TNFRSF8 Anticorps
TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Reactivité

  • 222
  • 42
  • 20
  • 16
Humain

Hôte

  • 116
  • 115
  • 18
  • 7
  • 6
  • 1
  • 1
Souris

Clonalité

  • 188
  • 74
  • 2
Monoclonal

Conjugué

  • 109
  • 22
  • 19
  • 17
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TNFRSF8 est conjugé à/à la FITC

Application

  • 125
  • 93
  • 75
  • 52
  • 41
  • 34
  • 27
  • 26
  • 14
  • 7
  • 7
  • 7
  • 7
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

MEM-268
  • Fonction

    Anti-Hu CD30 FITC

    Réactivité croisée (Details)

    Human

    Attributs du produit

    The antibody MEM-268 recognizes extracellular part of CD30 (Ki-1 antigen), a 105 kDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells, it is also found in Burkitt's lymphomas, virus-infected T and B lymphocytes, and on normal B and T lymphocytes after activation (T lymphocytes that produce Th2-type cytokines and on CD4+/CD8+ T lymphocytes that co-express CD45RO and the IL4 receptor).

    Purification

    Purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

    Immunogène

    Expression vector containing CD30 cDNA (booster suspension of THP-1 cell line)

    Isotype

    IgG2a, kappa
  • Indications d'application

    Flow cytometry: The reagent is designed for analysis of human blood cells using 20 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Do not freeze,Protect from prolonged exposure to light

    Stock

    4 °C

    Stockage commentaire

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Pavlov, Martins, Delgado: "Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing." dans: Clinical and vaccine immunology : CVI, Vol. 16, Issue 9, pp. 1327-31, (2009) (PubMed).

  • Antigène

    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

    Autre désignation

    CD30

    Sujet

    TNF receptor superfamily member 8,CD30 is a type I transmembrane glycoprotein of the TNF receptor superfamily. CD30 was originally identified as a cell surface antigen of Hodgkins and Reed-Sternberg cells using monoclonal antibody Ki-1. The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that co-express CD45RO and the IL4 receptor. Soluble form of CD30 (sCD30) serves as a marker reflecting Th2 immune response.,Ki-1, TNFRSF8, CD30L receptor, D1S166E

    ID gène

    943

    UniProt

    P28908
Vous êtes ici:
Chat with us!